Serum zinc levels and Alzheimer's disease

Biological Trace Element Research

Volumn 75, Issue 1-3, 2000, Pages 79-85

  Rulon, L L ^a   Robertson, J D ^a   Lovell, M A ^a,c   Deibel, M A ^a   Ehmann, W D ^a   Markesbery, W R ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Brain; FAAS; INAA; Serum; Zinc

Indexed keywords

ZINC;

ALZHEIMER DISEASE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD SAMPLING; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPIL; NEUTRON ACTIVATION ANALYSIS;

EID: 0033911861     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:75:1-3:79     Document Type: Article

References (28)

1. 1. R. Katzman, The prevalence and malignacy of Alzheimer's disease: a major killer, Arch. Neurol. 33, 217-218 (1976).
2. 2. D. A. Evans, H. H. Funkenstein, M. S. Albert, et al., Prevalence of Alzheimer's disease in a community population of older persons, JAMA 262, 2551-2556 (1989).
3. 3. W. R. Markesbery, Alzheimer's disease, in Diseases of the Nervous System: Clinical Neurobiology, A. K. Asbury, G. M. McKharr, and W. I. McDonald, eds., W. B. Saunders, Philadelphia, pp 195-803 (1992).
4. 4. F. M. Burnet, A possible role of zinc in the pathology of dementia, Lancet 1(8213), 186-188 (1981).
5. 2+-induced neurotoxicity in rat primary cortical cultures: involvement of L-type calcium channels, Brain Res. 654, 257-264 (1994).
6. 6. D. W. Choi, M. Yokoyama, and J. Koh, Zinc neurotoxicity in cortical cultures, Neuroscience 24, 67-79 (1988).
7. 7. M. W. Duncan, A. M. Marini, R. Watters. I. J. Kopin, and S. P. Markey, Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional Guamanian methods, J. Neurosci. 12, 1523-1537 (1992).
8. 8. M. I. Chuah, R. Tennet, and I. Jacobs, Response of olfactory Schwann cells to intranasal zinc sulfate irrigation, J. Neurosci. Res. 42, 470-478 (1995).
9. 9. M. P. Cuajungco and G. J. Lees, Prevention of zinc neurotoxicity in vivo by N,N,N′,N-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), NeuroReport 7, 1301-1304 (1996).
10. 10. A. I. Bush, W. H. Pettingel, G. Malthaup, et al., Rapid induction of Alzheimer Aβ amyloid formation by zinc, Science 265, 1464-1467 (1994).
11. 11. A. I. Bush, R. D. Moir, K. M. Rosenkranz, and R. E. Tanzi, Zinc and Alzheimer's disease, Science 268, 1921-1923 (1995).
12. 12. A. Clements, D. Allsop, D. M. Walsh, and C. H. Williams, Aggregation and metal binding of the mutant forms of the amyloid Aβ peptide of Alzheimer's disease, J. Neurochem. 66, 740-747 (1996).
13. 13. W. P. Esler, E. R. Stimson, J. M. Jennings, J. R. Ghilardi, P. W. Mantyh, and J. E. Maggio, Zinc induced aggregation of human and rat β amyloid peptides in vitro, J. Neurochem. 66, 723-732 (1996).
14. 14. M. A. Lovell, C. Xie, and W. R. Markesbery, Protection against amyloid beta peptide toxicity by zinc, Brain Res. 823, 88-95 (1999).
15. 15. M. A. Lovell, J. D. Robertson, W. J. Teesdale, J. L. Campbell, and W. R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J. Neurol. Sci. 158, 47-52 (1998).
16. 16. C. L. Tully, D. A. Snowdon, and W. R. Markesbery, Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study, NeuroReport 6, 2105-2108 (1995).
17. 17. A. Haines, S. Iliffe, P. Morgan, T. Dormandy, and B. Wood, Serum aluminum and zinc and other variables in patients with and without cognitive impairment in the community, Clin. Chim. Acta 198, 261-266 (1991).
18. 18. G. M. Craig, S. J. Evans, B. J. Brayshaw, and S. K. Raina, A study of serum zinc, albumin, alpha-2-macroglobulin and transferrin levels in acute and long stay elderly hospital patients, Postgrad. Med. J. 66, 205-209 (1990).
19. 19. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Juman Services Task Force on Alzheimer's Disease, Neurology 34, 939-944 (1984).
20. 20. The National Institute on Aging and Reagan Institute Working Group, Consensus recommendations for the postmortem diagnosis of Alzheimer's disease, Neurobiol. Aging 18, 51-52 (1997).
21. 21. P. C. H'Haese, L. V. Lamberts, A. O. Vanheule, and M. E. DeBroe, Direct determination of zinc in serum by Zeeman atomic absorption spectrometry with a graphite furnace, Clin. Chem. 38(12), 2439-2443 (1992).
22. 22. G. P. Butrimoviz and W. C. Purdy, The determination of zinc in blood plasma by atomic absorption spectrometry, Anal. Chim. Acta 94, 63-73 (1977).
23. 23. W. D. Ehmann, X.-X. Ding, S. S. Khare, M. A. Lovell, B.-F. Ni, L. Tandon, et al., Activation analysis in a multitechnique study of trace element imbalances in age-related neurological diseases, J. Radioanal. Nucl. Chem. 168, 223-231 (1993).
24. 24. G. V. Iyengar, W. E. Kollmer, and H. J. M. Bowen, The Elemental Composition of Human Tissues and Body Fluids: A Compilation of Values for Adults, Verlag Chemie, Weinheim, 1978.
25. 25. J. Versieck, J. Hoste, F. Barbier, H. Michels, and J. De Rudder, Simultaneous determination of iron, zinc, selenium, rubidium, and cesium in serum and packed blood cells by neutron activation analysis, Clin. Chem. 23, 1301-1305 (1977).
26. 26. F. Bjorksten, A. Aromaa, P. Knekt, and L. Malinen, Serum zinc concentrations in Finns, Acta Med. Scand. 204, 67-74 (1978).
27. 27. C. R. Cornett, W. R. Markesbery, and W. D. Ehmann, Imbalances of trace elements related to oxidative samage in Alzheimer's disease brain, NeuroToxicology 19(3), 339-346 (1998).
28. 28. E. Kienzl, K. Jellinger, W. Wruss, S. Horhager, and L. Puchinger, Distribution of individual elements in Alzheimer disease brain tissue, in Metal Ions in Biology and Medicine, vol. 4, P. Collery, J. Corbella, J. L. Domingo, J.-C. Etienne, and J. M. Llobet, eds., John Libbey Eurotext, New York, pp. 617-619 (1996).